Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort. | Diabetes Care;41(4): 840-846, 2018 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort.

Hunt, Kelly J; Jaffa, Miran A; Garrett, Sara M; Luttrell, Deirdre K; Lipson, Kenneth E; Lopes-Virella, Maria F; Luttrell, Louis M; Jaffa, Ayad A.

Diabetes Care ; 41(4): 840-846, 2018 04.

Article in En | MEDLINE | ID: mdl-29382658

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Connective Tissue Growth Factor / Myocardial Infarction Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Diabetes Care Year: 2018 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Connective Tissue Growth Factor / Myocardial Infarction Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Diabetes Care Year: 2018 Document type: Article Country of publication: